OncoMed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OMED and buy or sell other stocks, ETFs, and their options commission-free!About OMED
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F.
CEOJohn A. Lewicki, PhD
CEOJohn A. Lewicki, PhD
Employees—
Employees—
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded2004
Founded2004
Employees—
Employees—
OMED Key Statistics
Market cap34.41M
Market cap34.41M
Price-Earnings ratio-4.21
Price-Earnings ratio-4.21
Dividend yield—
Dividend yield—
Average volume1.23M
Average volume1.23M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.35
52 Week high$3.35
52 Week low$0.5467
52 Week low$0.5467
Stock Snapshot
OncoMed Pharmaceuticals(OMED) stock is priced at $0.89, giving the company a market capitalization of 34.41M. It carries a P/E multiple of -4.21.
OncoMed Pharmaceuticals(OMED) stock opened on 2025-11-05 at —. The price climbed to — and dipped to —.
The OncoMed Pharmaceuticals(OMED)'s current trading volume is 0, compared to an average daily volume of 1.23M.
In the last year, OncoMed Pharmaceuticals(OMED) shares hit a 52-week high of $3.35 and a 52-week low of $0.55.
In the last year, OncoMed Pharmaceuticals(OMED) shares hit a 52-week high of $3.35 and a 52-week low of $0.55.